Oxford

By Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool A scientist working at Oxford Vaccine Group’s laboratory facility at Churchill Hospital in Oxford.STEVE PARSONS/POOL/AFP via Getty Images Latest coronavirus news as of 5 pm on 20 July Oxford’s coronavirus vaccine candidate appears safe and induces immune response A coronavirus…

The coronavirus pandemic is still rapidly spreading across the globe, infecting more than 14.44 million people. With more than 188 countries and territories affected, scientists are racing to develop a vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19). One of the forerunners in this vaccine…

London's Telegraph reports that results from a Phase 1 clinical trial evaluating Oxford University's COVID-19 vaccine candidate ChAdOx1 nCoV-19 [ADZ1222 by licensee AstraZeneca (NYSE:AZN)] in healthy volunteers showed that it triggered a "double defense" immune response against the SARS-CoV-2 virus. Researchers noted that administration of the candidate produced both antibodies and killer T cells. The…

Sir John Bell, the Regius Professor of Medicine at Oxford University, said Sunday that researchers at the university working on a potential vaccine for the coronavirus would likely have an idea of its efficacy by June.Bell told NBC’s Chuck ToddCharles (Chuck) David ToddTrump blasts Fox News, says he wants 'an alternative' How autocrats are using…

In the global race to find a vaccine, Oxford University just jumped way ahead of the pack. Human testing is already underway, and scientists say they're hopeful a coronavirus vaccine will be widely available by September.Technology the lab had already developed in previous work on inoculations for other viruses, including a close relative of COVID-19,…